How to build on-the-ground excellence and protect critical business functions

This whitepaper explores:

• The growing need for business continuity planning
• Understanding the risk landscape
• Protecting critical functions and processes
• Ensuring on-the-ground operational engagement
• Adopting a mitigation mindset
• Business continuity planning in practice

Across the pharmaceutical supply chain, losses associated with temperature lapses are estimated to be worth £320bn globally.[1] To ensure the profitability of the pharmaceutical industry and patient safety, supply chains must limit the risk of damage to products.

Warehouses are a critical area of risk due to the hectic pace of operations and potential for errors in judgment or processes by workers. To ensure the safe storage and continuity of supply for pharmaceutical products, supply chain leaders must operate with smart warehouse management in mind.

In this report, we cover five areas where a company can improve warehouse operations:

• Smart warehouse management is integral to the efficient running of pharmaceutical supply chains
• Carefully weighing up the benefits and risks of a centralised or decentralised warehouse strategy
• Deciding when and where to use warehouse automation and technology
• Managing critical risk points in warehouse operations
• Ensuring a flexible warehousing strategy to meet market changes
• Integrating last mile distribution into warehousing

This in-depth, 15 page report takes a deep dive into:

• The latest Health Canada regulatory updates

• How Canada's cold chain leaders are combating drug shortages

• Cutting-edge last mile delivery innovations & solutions

Canada's life sciences temperature controlled supply chain has never been riper for disruption. In between evolving regulations and the emergence of game-changing technology such as AI and autonomous, the industry is poised for unprecedented change in 2020 and over the next decade. Download this special report to learn more about:

• GUI-0069 guidelines and projected 2020 updates
• Changes to the guidance on drug establishment licenses and associated fees
• 2020 GMP changes
• Licensing for atypical active pharmaceutical ingredients
• How AI and supply chain analytics are transforming the way biopharma firms confront drug shortages
• The current state of and the road ahead for autonomous trucking, real-time temperature control monitoring and AI-powered drone delivery